Boundless Bio, Inc.
BOLD
$1.13
-$0.04-3.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.64M | 19.45M | 18.00M | 16.42M | 15.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.40M | 73.73M | 73.27M | 68.79M | 65.02M |
| Operating Income | -71.40M | -73.73M | -73.27M | -68.79M | -65.02M |
| Income Before Tax | -64.39M | -65.69M | -65.36M | -61.06M | -57.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.39 | -65.69 | -65.36 | -61.06 | -57.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.39M | -65.69M | -65.36M | -61.06M | -57.72M |
| EBIT | -71.40M | -73.73M | -73.27M | -68.79M | -65.02M |
| EBITDA | -70.20M | -72.59M | -72.18M | -67.75M | -64.01M |
| EPS Basic | -2.89 | -2.96 | -14.52 | -23.55 | -33.52 |
| Normalized Basic EPS | -1.80 | -1.85 | -9.07 | -14.72 | -20.95 |
| EPS Diluted | -2.89 | -2.96 | -14.52 | -23.55 | -33.52 |
| Normalized Diluted EPS | -1.80 | -1.85 | -9.07 | -14.72 | -20.95 |
| Average Basic Shares Outstanding | 89.19M | 88.86M | 67.82M | 46.78M | 25.75M |
| Average Diluted Shares Outstanding | 89.19M | 88.86M | 67.82M | 46.78M | 25.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |